SEC Form 4 · accession 0000943819-26-000033
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J Rider
Officer — Global General Counsel
Period of report
Jun 1, 2026
Accepted (ET)
Jun 3, 2026 · 3:45 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common StockF1,F2 | Jun 1, 2026 | F | 269 | $190.57 | D | 9,488 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 06/01/2023.
- F2Includes 66.0288 shares of Resmed stock purchased on April 30, 2026 through the Resmed Employee Stock Purchase Plan.